COVID-19 vaccine associated demyelination & its association with MOG antibodyCOVID-19 백신 관련 탈수초화 및 MOG 항체와의 관련성Article Published on 2022-04-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age antibody association AstraZeneca Central nervous system ChAdOx1-S CNS CNS DEMYELINATION Complication control group COVID-19 COVID-19 vaccine CSF Demyelination died effective Encephalopathy FIVE glycoprotein immunogenic Infection lesion MOG multiaxial Myelin neurological adverse event occurred one patient Patient patients positive postvaccinial prolonged intensive care Protein raise raised reported Safe SARS-CoV-2 vaccine SARS-CoV-VACCINE. significantly higher susceptible individuals the vaccine triggered vaccination Vaccinations Vaccine [DOI] 10.1016/j.msard.2022.103739 PMC 바로가기 [Article Type] Article
Neurological Conditions Following COVID-19 Vaccinations: Chance or Association?Neurology Published on 2022-02-042022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome adverse event Adverse reaction affected astra zeneca covid-19 vaccine biological plausibility Case report case sery causal link cause ChAdOx1 nCoV-19 vaccine chance condition coronavirus Coronavirus disease 2019 COVID 19 COVID-19 COVID-19 vaccine criteria Diagnosis diagnostic workup Epidemiological study first dose Follow-up global pandemic Guillain-barrè syndrome hospital immunization incidence rate individual level management nervous system neurological neurological adverse event Neurological disease neurological side effects Patient Pfizer vaccine Pfizer-BioNTech Pfizer-BioNTech COVID-19 vaccine physician population level presenting symptoms provided reported safety profile SARS-CoV-2 Seizure subsequent syndrome Treatment vaccination Vaccine Vaccine adverse events Vaccine development vaccine side effects Vaccines virus was determined while World Health Organization Wuhan, China [DOI] 10.7759/cureus.21919 PMC 바로가기 [Article Type] Neurology
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 VaccinesNeurology Published on 2022-01-182022-10-31 Journal: Cureus [Category] COVID-19, [키워드] administration Adverse adverse effect adverse events Adverse events following immunization AEs Ageusia Analysis Anosmia approval association AZD1222 BNT162b2 BNT162b2 vaccine carried clinical trials conducted COVID-19 COVID-19 vaccine COVID-19 vaccines database Descriptive statistics Dizziness eight event facial paralysis Frequency headache lethargy Long-term follow-up mRNA-1273 mRNA-1273 vaccine neurological neurological adverse event Neurological disorder Neurological disorders neurological system pandemic post-COVID-19 vaccination reported sars-cov-2 (severe acute respiratory syndrome coronavirus -2) Seizure sleep quality study period System the vaccine the WHO vaccination Vaccine Vero with COVID-19 [DOI] 10.7759/cureus.21376 PMC 바로가기 [Article Type] Neurology